News

Merck & Co has filed a lawsuit against ... and Human Services will be able to negotiate the prices of selected drugs with a “high budget impact” provided via Medicare Parts B and D, starting ...
Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...
Merck & Co.‘s planned debut this fall of an injectable form of its breakthrough cancer treatment Keytruda will simplify care, ...
Uncertainty around pharma tariffs on and pricing policies under the Trump has much of the sector guessing what will happen ...
Shares of U.S. drugmakers rebounded on Monday after an initial selloff as analysts said that President Donald Trump's ...
Pharmacy stocks, including Eli Lilly (LLY), Johnson & Johnson (JNJ), and Merck (MRK), are moving to the downside after US President Trump said he will cut drug prices by over 50%. To watch more ...
Patients will likely eventually see higher prices and drug shortages under President Trump's plan to assess tariffs on ...
President Donald Trump signed an executive order this week setting a 30-day deadline for drugmakers to electively lower ...